Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents
Top Cited Papers
- 1 February 2017
- journal article
- clinical trial
- Published by Elsevier BV in Bone
- Vol. 95, 11-19
- https://doi.org/10.1016/j.bone.2016.11.008
Abstract
No abstract availableKeywords
Funding Information
- Abbott
This publication has 34 references indexed in Scilit:
- Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case–controlled study (ENIGI)Acta Endocrinologica, 2015
- Bone Mass in Young Adulthood Following Gonadotropin-Releasing Hormone Analog Treatment and Cross-Sex Hormone Treatment in Adolescents With Gender DysphoriaJournal of Clinical Endocrinology & Metabolism, 2015
- Approach to the Patient: Transgender Youth: Endocrine ConsiderationsJournal of Clinical Endocrinology & Metabolism, 2014
- Bone Mass, Bone Geometry, and Body Composition in Female-to-Male Transsexual Persons after Long-Term Cross-Sex Hormonal TherapyJournal of Clinical Endocrinology & Metabolism, 2012
- Puberty Suppression in Adolescents With Gender Identity Disorder: A Prospective Follow-Up StudyThe Journal of Sexual Medicine, 2011
- Puberty Suppression in a Gender-Dysphoric Adolescent: A 22-Year Follow-UpArchives of Sexual Behavior, 2011
- Sex- and Age-Specific Reference Curves for Serum Markers of Bone Turnover in Healthy Children from 2 Months to 18 YearsJournal of Clinical Endocrinology & Metabolism, 2006
- Bone mineral density in girls and boys at different pubertal stages: relation with gonadal steroids, bone formation markers, and growth parametersJournal of Bone and Mineral Metabolism, 2005
- Bone development during GH and GnRH analog treatmentActa Endocrinologica, 2004
- Biochemical markers of bone turnover in girls during pubertyClinical Endocrinology, 1994